Role of radiation therapy in localized aggressive lymphoma

被引:16
作者
Ng, Andrea K. [1 ]
Mauch, Peter M. [1 ]
机构
[1] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dana Farber Canc Inst,Dept Radiat Oncol, Boston, MA 02115 USA
关键词
D O I
10.1200/JCO.2006.09.5562
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:757 / 759
页数:3
相关论文
共 14 条
[1]  
Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0
[2]   CHOP alone compared with CHOP plus radiotherapy for localized aggressive lymphoma in elderly patients:: A study by the Groupe d'Etude des Lymphomes de I'Adulte [J].
Bonnet, Christophe ;
Fillet, Georges ;
Mounier, Nicolas ;
Ganem, Gard ;
Molina, Thierry Jo ;
Thieblemont, Catherine ;
Ferme, Christophe ;
Quesnel, Bruno ;
Martin, Claude ;
Gisselbrecht, Christian ;
Tilly, Herve ;
Reyes, Felix .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (07) :787-792
[3]   Intensity-modulated radiation therapy reduces late salivary toxicity without compromising tumor control in patients with oropharyngeal carcinoma: a comparisons with conventional techniques [J].
Chao, KSC ;
Majhail, N ;
Huang, CJ ;
Simpson, JR ;
Perez, CA ;
Haughey, B ;
Spector, G .
RADIOTHERAPY AND ONCOLOGY, 2001, 61 (03) :275-280
[4]   CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. [J].
Coiffier, B ;
Lepage, E ;
Brière, J ;
Herbrecht, R ;
Tilly, H ;
Bouabdallah, R ;
Morel, P ;
Van den Neste, E ;
Salles, G ;
Gaulard, P ;
Reyes, F ;
Gisselbrecht, C .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (04) :235-242
[5]  
Fisher Richard I, 2004, Hematology Am Soc Hematol Educ Program, P221
[6]   Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma [J].
Habermann, Thomas M. ;
Weller, Edie A. ;
Morrison, Vicki A. ;
Gascoyne, Randy D. ;
Cassileth, Peter A. ;
Cohn, Jeffrey B. ;
Dakhil, Shaker R. ;
Woda, Bruce ;
Fisher, Richard I. ;
Peterson, Bruce A. ;
Horning, Sandra J. .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (19) :3121-3127
[7]   Chemotherapy with or without radiotherapy in limited-stage diffuse aggressive non-Hodgkin's lymphoma: Eastern cooperative oncology group study 1484 [J].
Horning, SJ ;
Weller, E ;
Kim, KM ;
Earle, JD ;
O'Connell, MJ ;
Habermann, TM ;
Glick, JH .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (15) :3032-3038
[8]  
Miller TP, 2001, BLOOD, V98, p724A
[9]   Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate-and high-grade non-Hodgkin's lymphoma [J].
Miller, TP ;
Dahlberg, S ;
Cassady, JR ;
Adelstein, DJ ;
Spier, CM ;
Grogan, TM ;
LeBlanc, M ;
Carlin, S ;
Chase, E ;
Fisher, RI .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (01) :21-26
[10]   CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma:: a randomised controlled trial by the MabThera International Trial (MInT) Group [J].
Pfreundschuh, Michael ;
Trumper, Lorenz ;
Osterborg, Anders ;
Pettengell, Ruth ;
Trneny, Marek ;
Imrie, Kevin ;
Ma, David ;
Gill, Devinder ;
Walewski, Jan ;
Zinzani, Pier-Luigi ;
Stahel, Rolf ;
Kvaloy, Stein ;
Shpilberg, Ofer ;
Jaeger, Ulrich ;
Hansen, Mads ;
Lehtinen, Tuula ;
Lopez-Guillermo, Armando ;
Corrado, Claudia ;
Scheliga, Adriana ;
Milpied, Noel ;
Mendila, Myriam ;
Rashford, Michelle ;
Kuhnt, Evelyn ;
Loeffler, Markus .
LANCET ONCOLOGY, 2006, 7 (05) :379-391